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a b s t r a c t
Solitary ﬁbrous tumours (SFTs) are rare WHO grade I mesenchymal neoplasms that were
ﬁrst described in the visceral pleura. A wide variety of locations of SFT have been reported
but only twelve cases of intramedullary solitary ﬁbrous tumour. We report a case of thoracic
spinal cord SFT.
A 49-year-old woman presented with clinical signs of dorsal myelopathy. Magnetic
resonance imaging revealed an intradural mass at level T9–T10 which showed imaging
features consistent both for an intra- and an extramedullary location of a solid tumour.
Imaging ﬁndings were conﬁrmed during surgery which was successful in resecting the
extramedullary component. The intramedullary component could only be partially
resected.
Solitary ﬁbrous tumour is a rare pathological entity in the central nervous system. The
course of intramedullary SFT is unknown and careful long-term follow-up is recommended.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Solitary ﬁbrous tumour (SFT) is a rare neoplasm of mesenchy-
mal origin that arise most commonly in the visceral pleura [1].
Solitary ﬁbrous tumour can occur in a variety of other sites [2–
5], including the central nervous system (CNS). Solitary ﬁbrous
tumours in CNS are usually dural based, meningioma-like
masses [6–8]. Only few isolated cases of intramedullary SFT are
described in the literature [9–17]. We report a case of
intramedullary SFT with extramedullar component and
review the literature.* Corresponding author.
E-mail address: Thomas.robert43@gmail.com (T. Robert).
0028-3843/$ – see front matter # 2014 Polish Neurological Society. Pu
http://dx.doi.org/10.1016/j.pjnns.2013.09.0062. Case report
A 49-year-old Caucasian woman presented for over one-year
history of bilateral lower extremities numbness and paresthe-
sia predominately on the right side associated with progres-
sive inability to walk. She also described nocturnal back pain
which forced her to stand up. General physical examination
was normal. Neurological examination revealed decreased
pain, light touch and joint position sensations below the T12
level. The legs were severely spastic, rendering the walk
difﬁcult. Increased deep tendon reﬂexes were demonstratedblished by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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objective sphincter disturbances.
Magnetic resonance imaging (MRI) revealed an intradural
mass measuring 13 mm longitudinally at the level T9–T10
(Fig. 1). The cranial component of the tumour seemed to be
intramedullary and involved the posterior horns bilaterally. The
caudal part was extramedullary and bulged posteriorly. There
was no apparent inﬁltration of the dura mater or the posterior
nerve roots. The mass was strongly hypointense to the spinal
cord on spin-echo T2-weighted images and echo-gradient T2-
weighted images with no blooming effect suggesting highFig. 1 – (A) Sagittal T2-weighted magnetic resonance (MR) image
surrounded by oedema. (B) Sagittal T1-weighted MR image conf
sagittal (C) and axial (D) MR images reveal homogeneous enhancellularity. The mass appeared mildly hypointense to the spinal
cord on T1-weighted images with homogenous enhancement
after gadolinium administration. The lesion was surrounded by
intramedullary vasogenic oedema predominantly around the
upper aspect of the tumour, extending over one vertebral level.
No dural attachment and no ‘‘dural tail’’ were demonstrated on
the gadolinium-enhanced studies.
Surgery was performed by a T9–T10 laminectomy approach.
The tumour was deﬁnitely intramedullary in origin but was
eccentric at the caudal aspect. The tumour appeared immedi-
ately, covered by an arachnoid layer. The tumour arouse clearly demonstrates a low-intensity intramedullary tumour
irms the presence of isointense tumour. Post-gadolinium
cement.
Fig. 3 – Postoperative sagittal T2-weighted (A) and T1-weig
Fig. 2 – Photomicrographs stained with HE showing a
proliferation of predominantly spindle-shaped cells
without atypia, mitoses and necroses (A).
Immunohistochemical staining is positive for CD34 (B).
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The cranial part of the tumour was imbedded in the medulla
while the caudal part extruded and could appear as extra-
medullary. The tumour was very hard and ultrasonic aspirator
could not aspirate it. We performed a piecemeal intracavitary
excision. There was no cleavage plane between the tumour and
the surrounded medulla. According to this, a complete excision
of the tumour would have harboured a tremendous risk of
neurological worsening and we decided to do a partial excision
(Fig. 2).
The histological examination of the tumour demonstrated
a solid proliferation of spindle-shaped cells with a patternless
or fascicular growth pattern associated to a collagenous matrix
background (Fig. 3). The immunohistochemical staining
showed a strong and diffuse positivity for CD34 and Bcl-2.
There was no mitosis and no necrosis. The proliferation index
of the tumour, analysed with Mib-1 (Ki-67), was smaller than
1%. The tumour cells were negative for keratin, EMA, CD117,
DOG1 and S-100 protein. The negativity for S-100 argued
against nervous tumour such as schwannoma or neuroﬁbro-
ma; the negativity for EMA – against perineurinoma or
meningioma. The overall morphology of the tumour was
consistent with a SFT.
There was worsening of the joint position sense and the
walk on the ﬁrst postoperative week, but this had totally
recovered in one month. Postoperative MRI demonstrated
partial removal of the lesion with increased intramedullary
oedema. It increased even if the patient has been operated.
Six months postoperatively, the neurological examination
was normal and the patient was back to normal life and to
work.
3. Discussion
Solitary ﬁbrous tumour is a mesenchymal tumour that arises
most commonly in the visceral pleura [1]. Histologically, thehted (B) MR images after partial removal of the lesion.
Table 1 – Literature reports of intramedullary solitary fibrous tumour.
Described by Year Age Sex Location Signs Aspect Treatment Clinical outcome Recurrence Follow-up
Carneiro et al. [9] 1996 50 M Conus Cono-caudal syndrome Intra- and extramedullary Total removal Totally improved Yes 5 years
Alston et al. [10] 1997 47 M T4–T5 Brown-Sequard syndrome Purely intramedullary Total removal Partially improved No 2 months
Kanahara et al. [11] 1998 62 M C6–C7 Cervical myelopathy Dorsal portion, partially
extramedullary
Total removal ND Not
described
Not
described
Mordani et al. [12] 2000 33 M C5 Cervical myelopathy Dorsal portion,
predominantly
intramedullary
Total removal ND No 18 months
Kawamura et al. [13] 2004 64 M T2–T3 Brown Sequard syndrome Right-sided, partially
extramedullary
Partial removal ND No 6 months
Jallo et al. [14] 2005 59 M T5 Dorsal myelopathy ND Total removal ND No 4.8 years
Jallo et al. [14] 2005 37 F T2–T3 Paresthesias ND Total removal ND No 5 years
Jallo et al. [14] 2005 41 M C6–C7 Cervical myelopathy Eccentric, partially
extramedullary
Total removal ND No 3.5 years
Jallo et al. [14] 2005 17 M T5–T6 Scoliosis Right-sided, partially
extramedullary
Total removal No neurological
deﬁcit
No 1.6 years
Ogungbo et al. [15] 2005 53 M C3–C4 Cervical myelopathy Two-thirds intramedullary ND Improvement in
numbness and gait
ND ND
Ishii et al. [16] 2009 63 F C5 Paresthesias Purely intramedullary Total removal Totally improved No 14 months
Ciappetta et al. [17] 2010 75 F T6–T7 Dorsal myelopathy Right-sided, partially
extramedullary
Total removal Totally improved No 24 months
Present case 2011 49 F T9–T10 Dorsal myelopathy Dorsal portion, partially
extramedullary
Partial removal Partially improved No 6 months
ND – Not Described.
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features has been described [5–8,18–21]. The completeness of
resection and the histological appearance are the most
important recognized prognostic factors [5–8]. Since the ﬁrst
case of pleural SFT described by Klemperer and Rabin [1] in
1931, a wide variety of extra-pleural locations of SFT such as
liver [22], thyroid [23] and orbit [24] have been reported [25].
Solitary ﬁbrous tumour of the CNS is included in the 2000
World Health Organization classiﬁcation in the category of
mesenchymal neoplasm [6]. SFT of the CNS is a distinct
clinico-pathologic entity with similarities to ﬁbrous meningi-
oma and hemangiopericytoma [5,7]. The pathological diagno-
sis of SFT is a strong and diffuse positivity for CD34 and Bcl2
without any mitoses or necrosis. Differential diagnosis such as
meningioma, schwannoma or neuroﬁbroma is based on the
negativity of the other immunohistochemical staining [26].
SFT of the CNS generally affects adults and tend to arise
predominantly in the posterior fossa and the spinal column
[6]. Five cases [5–7,18,21] of intraspinal and intracranial SFT
with multiple locations have been described and Tachenouchi
[18] reported a case of drop metastases after complete
resection of a right fronto-parietal SFT.
Only few isolated cases [9–17] of intramedullary SFT are
described in the literature (Table 1). First reported by Carneiro
et al. in 1996, we reviewed 12 cases by a systematic analysis of
Pubmed support. The median age at presentation is 50 years
(range: 17–75 years) and sex ratio (M/F) is 2.25. The cervical
(38%) and upper thoracic (46%) spine are the most frequent
locations. Ninety-two percent (12/13) of the cases disclosed
progressive neurologic deﬁcits and 69% (9/13) presented an
intradural extramedullary extension with dural-based attach-
ment seen at surgery. In 76% (10/13), total resection could be
accomplished with only one case of tumoural recurrence.
In studies about SFT of the CNS, these tumours seemed to be
successfully managed by surgery alone [5–7,27–29]. Published
data suggest that hypercellularity, marked nuclear atypia, high
mitotic activity and a high proliferation index are risk factors for
recurrence [1–4,30,31]. These ﬁndings were based on isolated
cases of intramedullary SFT [9–17] as no case series are reported
in the literature. Total removal of intramedullary SFT without
worsening of neurological signs is, however, less easily achieved
than in others locations. In the majority of reports of
intramedullary SFT, the margins between the tumour and the
spinal cord were not clear at surgery [10,12,13,16] as in our case
where no cleavage plane existed between the cranial portion of
the lesion and the spinal cord, precluding complete resection of
the lesion. So, we would like to highlight that complete removal
of intramedullary SFT could be technically difﬁcult and could
complicate the following management.
There are no clear data about the efﬁcacy of adjuvant therapy
(chemotherapy and radiotherapy) on recurrence, regrowth and
progression of the lesion in case of intramedullary SFT [5–8]. The
place of postoperative radiotherapy in partially resected or
histologically atypical CNS SFTs is still unknown but is often
chosen as analogous to the treatment of current meningeal
tumours. Very few cases of SFT of the CNS treated by
radiotherapy have been described [5–8] in the literature.
According to the literature, long follow-up is recommended
after MRI due to the unpredictable behaviour of some SFT [1–
8,25]. Few studies [5–9,18,21,32] reported recurrence of SFT ofthe CNS several years after the ﬁrst clinical manifestation.
Magnetic resonance imaging of the neuraxis is recommended
every year for the follow-up, although complete resection has
been performed. The duration of follow-up is difﬁcult to
establish but we could propose a minimum of ten years
regarding data about SFT in the CNS.
No data are available in the literature about management of
recurrence or regrowth of the lesion. We think that the more
appropriate is a second-look surgery without complement
radiotherapy.
4. Conclusion
Although SFTs are generally benign lesions, malignant cases of
SFTs have been reported. In such cases, recurrence and
metastasis may take place even after complete resection.
Because of the rarity of reports and the lack of long-term
follow-up, the course of intramedullary SFT is unknown and
careful long-term follow-up is recommended. Magnetic reso-
nance imaging of the neuraxis is the imaging of choice for the
follow-up.
Conﬂict of interest
None declared.
Acknowledgement and ﬁnancial support
None declared.
Ethics
The work described in this article has been carried out in
accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments involv-
ing humans; Uniform Requirements for manuscripts submit-
ted to Biomedical journals.
r e f e r e n c e s
[1] Klemperer P, Rabin CB. Primary neoplasms of the pleura.
Arch Pathol 1931;11:385–412.
[2] Bortolotti U, Calabro F, Loy M, Fasoli G, Altavilla G,
Marchese D. Giant pericardial solitary ﬁbrous tumor.
Ann Thorac Surg 1992;54:1219–20.
[3] El-Naggar AK, Ro JY, Ayala AG, Ward R, Ordonez NG.
Localized ﬁbrous tumor of the serosal cavities:
immunohistochemical, electron-microscopic, and ﬂow-
cytometric DNS study. Am J Clin Pathol 1989;92:561–5.
[4] Hanau CA, Miettinen M. Solitary ﬁbrous tumor: histological
and immunohistochemical spectrum of benign and
malignant variants presenting at different sites. Hum
Pathol 1995;26:440–9.
[5] Vorster SJ, Prayson RA, Lee JH. Solitary ﬁbrous tumor of the
thoracic spine. J Neurosurg (Spine 2) 2000;92:217–20.
[6] Metellus P, Bouvier C, Guyotat J, Fuentes S, Jouvet A,
Vasiljevic A, et al. Solitary ﬁbrous tumors of the central
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 4 4 – 1 4 9 149nervous system: clinicopathological and therapeutic
considerations of 18 cases. Neurosurgery 2007;60:715–21.
[7] Johnson MD, Powell SZ, Boyer PJ. Dural lesions mimicking
meningiomas. Hum Pathol 2002;33:1211–26.
[8] Tihan T, Viglione M, Rosenblum MK, Olivi A, Burger PC.
Solitary ﬁbrous tumors in the central nervous system. Arch
Pathol Lab Med 2003;127:432–9.
[9] Carneiro SS, Scheithauser BW, Nascimento AG, Hirose T,
Davis DH. Solitary ﬁbrous tumor of the meninges: a lesion
distinct from ﬁbrous meningioma. Am J Clin Pathol
1996;106:217–24.
[10] Alston SR, Francel PC, Jane JA. Solitary ﬁbrous tumors of the
spinal cord. Am J Surg Pathol 1997;21:477–83.
[11] Kanahara T, Hirokawa M, Shimizu M. Solitary ﬁbrous
tumors of the spinal cord: report of a case with scrape
cytology. Acta Cytol 1998;43:425–8.
[12] Mordani JP, Haq IU, Singh J. Solitary ﬁbrous tumors of the
spinal cord. Neuroradiology 2005;42:679–81.
[13] Kawamura M, Izawa K, Hosono N, Hirano H. Solitary ﬁbrous
tumors of the spinal cord: case report and review of the
literature. Neurosurgery 2004;55:433–8.
[14] Jallo GI, Roonprapunt C, Kothbauer K, Freed D, Allen J,
Epstein F. Spinal solitary ﬁbrous tumors: a series of four
patients. Neurosurgery 2005;57:195–200.
[15] Ogungbo B, Prakash S, Kulkarni G, Bradey N, Marks SM,
Scoones D. Cervical intra-/extramedullary solitary ﬁbrous
tumor. Br J Neurosurg 2005;19:254–7.
[16] Ishii K, Nakamura M, Masumoto M, Mukai M, Toyama Y,
Chiba K. Intramedullary solitary ﬁbrous tumor of the spinal
cord. J Orthop Sci 2009;14:450–4.
[17] Ciappetta P, D'Urso PI, Cimmino A. Intramedullary solitary
ﬁbrous tumors of dorsal spinal cord. Neuropathology
2010;30:273–8.
[18] Tackenouchi T, Pannullo SC, Stieg PE. Solitary ﬁbrous tumor
with multiple intracranial and spinal lesions: case report.
Neurosurgery 2001;68:1148–51.
[19] Aftab S, Casey A, Tirabosco R. Fat-forming solitary ﬁbrous
tumor (lipomatous haemangiopericytoma) of the spine: case
report and literature review. Skeletal Radiol 2001;39:1039–42.[20] Kakimaru H, Matsusaki M, Sanada H. Dumbbell-type spinal
solitary ﬁbrous tumor with paraplegia. Orthopedics
2009;32:213.
[21] Munoz E, Prat A, Adamo B, Peralta S, Ramon y Cajal S,
Valverde C. A rare case of malignant solitary ﬁbrous tumor
of the spinal cord. Spine 2008;33:397–9.
[22] Kottke-Marchant K, Hart WR, Broughan T. Localized ﬁbrous
tumor of the liver. Cancer 1989;64:1096–102.
[23] Cameselle-Teijeiro J. Solitary ﬁbrous tumor of the thyroid.
Am J Clin Pathol 1994;101:535–8.
[24] Dorfman DM. Solitary ﬁbrous tumor of the orbit. Am J Surg
Pathol 1994;18:281–7.
[25] Daigeler A, Lehnardt M, Langer S, Steinstrasser L, Steinau H,
Mentzel T, et al. Clinicopathological ﬁndings in a case series
of extrathoracic solitary ﬁbrous tumors of soft tissues. BMC
Surg 2006;6:10.
[26] Chomik P, Michcik A, Michajłowski I. Solitary ﬁbrous tumor
in the oral cavity: a case report and diagnostic dilemma.
Postep Derm Alergol 2012;29:395–400.
[27] Ogawa T, Moriyama E, Beck H, Sonobe H. Solitary ﬁbrous
tumor of the thoracic spinal cord. Neurol Med Chir (Tokyo)
2005;45:371–5.
[28] Malek AM, Weller SJ, Price DL, Madsen JR. Solitary ﬁbrous
tumor presenting as a symptomatic intraspinal mass: case
report. Neurosurgery 1997;40:844–7.
[29] Kurtkaya O, Elmaci I, Sav A, Pamir MN. Spinal solitary
ﬁbrous tumor: seventh reported case and review of the
literature. Spinal Cord 2001;39:57–60.
[30] Vassal F, Manet R, Forest F, Camdessanche JP, Peoch M,
Nuti C. Solitary ﬁbrous tumors of the central nervous
system: report of ﬁve cases with clinicopathological and
outcome patterns. Acta Neurochir 2008;153:377–84.
[31] Caroli E, Salvati M, Orlando ER, Lenzi J, Santoro A,
Giangaspero F. Solitary ﬁbrous tumors of the meninges.
Neurosurg Rev 2004;27:246–51.
[32] Kataoka H, Akiyama Y, Kubo S, Itoh H, Hamasuna R,
Tajima H, et al. Solitary ﬁbrous tumors of the spinal nerve
rootlet: case report and literature survey. Pathol Int
1999;49:826–30.
